Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation

Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation

Bibliographic Details
Main Authors:	Yuriko Ishida, Satoshi Ikeda, Akimasa Sekine, Tomohisa Baba, Takashi Ogura
Format:	Article
Language:	English
Published:	European Respiratory Society 2022-12-01
Series:	ERJ Open Research
Online Access:	http://openres.ersjournals.com/content/8/4/00337-2022.full

Similar Items

Current Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia
by: Satoshi Ikeda, et al.
Published: (2021-08-01)

Patients with Terminal Interstitial Pneumonia Require Comparable or More Palliative Pharmacotherapy for Refractory Dyspnea than Patients with Terminal Lung Cancer
by: Hiroko Okabayashi, et al.
Published: (2021-06-01)

Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
by: Manuela Funke-Chambour, et al.
Published: (2022-12-01)

<i>KRAS<sup>G12C</sup></i> Inhibitor as a Treatment Option for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia
by: Kazushi Fujimoto, et al.
Published: (2024-03-01)

Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy
by: Akimasa Sekine, et al.
Published: (2022-09-01)

Concordance between transbronchial lung cryobiopsy and surgical lung biopsy for interstitial lung disease in the same patients
by: Tomohisa Baba, et al.
Published: (2023-07-01)

Effects of Automatic Deep-Learning-Based Lung Analysis on Quantification of Interstitial Lung Disease: Correlation with Pulmonary Function Test Results and Prognosis
by: Ryo Aoki, et al.
Published: (2022-12-01)

Hemoptysis due to pulmonary infarction in COVID-19
by: Sho Yamada, et al.
Published: (2022-07-01)

CT-based lung motion differences in patients with usual interstitial pneumonia and nonspecific interstitial pneumonia
by: Jiwoong Choi, et al.
Published: (2022-10-01)

Pharmacotherapy for Advanced Non-Small Cell Lung Cancer with Performance Status 2 without Druggable Gene Alterations: Could Immune Checkpoint Inhibitors Be a Game Changer?
by: Satoshi Ikeda, et al.
Published: (2022-10-01)

Expression of HSP47 in Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia
by: Mine Mariko, et al.
Published: (2005-06-01)

Choosing the appropriate pharmacotherapy for nonspecific chronic low back pain
by: Filippo Migliorini, et al.
Published: (2022-12-01)

Radiological and Pathological Features of Cyst Formation in Idiopathic Multicentric Castleman Disease
by: Ryota Otoshi, et al.
Published: (2023-04-01)

Safety and Efficacy of Single-Fraction Carbon-Ion Radiotherapy for Early-Stage Lung Cancer with Interstitial Pneumonia
by: Shuri Aoki, et al.
Published: (2024-01-01)

General principles of pharmacotherapy selection in elderly patients for different comorbidities
by: M. Stuhec
Published: (2022-06-01)

Modern approaches to pharmacotherapy of Community-Acquired Pneumonia
by: Anna A. Gavrilova, et al.
Published: (2020-12-01)

Interstitial Lung Fibrosis Following COVID-19 Pneumonia
by: Mihai Lazar, et al.
Published: (2022-08-01)

Quantitative Analysis for Lung Disease on Thin-Section CT
by: Tae Iwasawa, et al.
Published: (2023-09-01)

Interstitial pneumonia with autoimmune features
by: Uma Karjigi, et al.
Published: (2021-01-01)

Idiopathic Lymphocytic Interstitial Pneumonia
Published: (2016-03-01)

Anti-EJ antibody-positive interstitial pneumonia with breast cancer improved by combining immunosuppressive therapy and chemotherapy
by: Ai Koike, et al.
Published: (2023-01-01)

Frequency of subclinical interstitial lung disease in COVID-19 autopsy cases: potential risk factors of severe pneumonia
by: Hiromichi Iwashita, et al.
Published: (2023-10-01)

The Impact of Comorbid Chronic Pain on Pharmacotherapy for Veterans with Post-Traumatic Stress Disorder
by: Alessandra A. Pratt, et al.
Published: (2023-07-01)

Successfully Treated Acute Interstitial Pneumonia
by: Marija Gomerčić Palčić, et al.
Published: (2022-01-01)

Acute interstitial pneumonia in nongrazing cows
by: Hasan BATMAZ, et al.
Published: (2021-09-01)

Clinical significance of microscopic polyangiitis with interstitial lung disease and bronchiectasis: probability of preexisting comorbidities
by: Yun Zhang, et al.
Published: (2023-12-01)

Comparison of Clinical Characteristics and Outcomes between Idiopathic and Secondary Pleuroparenchymal Fibroelastosis
by: Tsuneyuki Oda, et al.
Published: (2021-02-01)

Diagnostic Value of Connective Tissue Disease Related CT Signs in Usual Interstitial Pneumonia Pattern of Interstitial Lung Disease
by: Antony Augustine, et al.
Published: (2023-01-01)

Positive Autoantibody Is Associated with Malignancies in Patients with Idiopathic Interstitial Pneumonias
by: Takuma Koga, et al.
Published: (2022-10-01)

Studying the characteristics of interstitial pneumonia with autoimmune features
by: Nabila Laza, et al.
Published: (2020-06-01)

Nonspecific interstitial pneumonia revealing an antisynthetase syndrome
by: Nedia Moussa, et al.
Published: (2022-11-01)

Interstitial pneumonia following exposure to fluorocarbon polymers
by: Eduardo Algranti, et al.
Published: (2014-01-01)

Three cases of desquamative interstitial pneumonia (DIP)
by: Tabatabaie P, et al.
Published: (1997-04-01)

Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review
by: Hideaki Yamakawa, et al.
Published: (2022-07-01)

Hypersensitivity pneumonitis with Paecilomyces as suspected inciting antigen
by: Masayuki Watanabe, et al.
Published: (2024-01-01)

Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)
by: Hideaki Yamakawa, et al.
Published: (2021-08-01)

The Pattern and Progression of “Usual” Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis
by: Alessandro Libra, et al.
Published: (2024-01-01)

Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort study
by: Natalia Mena-Vázquez, et al.
Published: (2023-01-01)

Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis
by: I. A. Narkevich, et al.
Published: (2019-01-01)

Clinical Case of Idiopathic Interstitial Pneumonia: Expert Approaches
by: V. M. Karetnikova, et al.
Published: (2019-05-01)